University of California San Francisco
UCSF School of Dentistry Professor M. Anthony Pogrel received the 2009 William J. Gies Foundation Award, which recognizes educators for distinguished achievements in the specialty of oral and maxillofacial surgery.
A study conducted by researchers at the San Francisco VA Medical Center and the University of California, San Francisco offers evidence that veterans with post-traumatic stress disorder have a significantly lower survival rate one year after surgery than veterans without the diagnosis, even though the veterans with PTSD were seven years younger on average.
Twenty years of screening for breast and prostate cancer – the most diagnosed cancer for women and men – have not brought the anticipated decline in deaths from these diseases, argue experts from the University of California, San Francisco and the University of Texas Health Science Center at San Antonio in an opinion piece published in the “Journal of the American Medical Association.”
A walking tour of Mount Sutro is scheduled for noon on Saturday, Oct. 24. Those who want to join the tour should meet at the intersection of Johnstone Drive and Behr Avenue.
UCSF will offer a chance for people with colorectal cancer to meet with and learn from experts and fellow patients living with the disease at an event on October 31.
Margaret Chesney will return to UCSF as the director of the UCSF Osher Center for Integrative Medicine</a>, effective Jan. 1, 2010.
In a conversation with Chancellor Sue Desmond-Hellmann, newly named Nobel laureate Elizabeth Blackburn covered a range of topics, including career highs and lows and the particular struggles of working women.
A new report finds widespread variations and frequent errors in HER2 testing — a procedure recommended for all patients with invasive breast cancer.
The sixth-annual Research and Clinical Excellence Day paid tribute to the scientific breakthroughs and high-quality patient care that have helped make the UCSF School of Dentistry an international leader in advancing health.
UCSF leaders took the stage recently to promote interprofessional collaboration and call attention to health care disparities.
The Kaiser Permanente Research Program on Genes, Environment, and Health (RPGEH) and the University of California, San Francisco (UCSF) have been awarded $24.8 million over two years by the National Institutes of Health (NIH) to create a new resource for studying disease, health, and aging.
Five UCSF faculty scientists are among the 65 newly elected members to the Institute of Medicine (IOM), part of the National Academy of Sciences. Election to IOM is considered one of the highest honors in the fields of health and medicine. The new members were announced today (Oct. 12, 2009) at the IOM annual meeting.
UCSF has opened a state-of-the-art facility at Mission Bay that provides custom-tailored care to all patients, from professional athletes to amputees.
New UCSF Faculty, October 2009
Presentation by Ambassador Stephen Lewis, co-director, AIDS-Free World and U.N. special envoy for HIV/AIDS in Africa (2001-2006), follow by panel discussion and reception. Lewis will be introduced by UCSF Chancellor Susan Desmond-Hellmann, MD, MPH.
New UCSF Faculty, October 2009
New UCSF Faculty, October 2009
New UCSF Faculty, October 2009
New UCSF Faculty, October 2009
UCSF has launched a website to serve as a source of information for faculty, staff and trainees, who have questions about the medical group’s new relationship with Hill Physicians Medical Group.
Dean Schillinger, director of the UCSF Center for Vulnerable Populations (CVP) at San Francisco General Hospital, received a national award for research leading to better communication in health care.
From anxiety to exhilaration to burgers with the boss, the 14 members of Elizabeth Blackburn's lab share the exciting hours surrounding the Oct. 5 Nobel Prize announcement.
A recent two-day symposium at UCSF offered leading stem cell experts a chance to talk shop and form new alliances in the fight against neurological disorders.
The University of California, San Francisco has been designated to lead a new consortium that will study a group of severe immune disorders known as primary immunodeficiencies and aims to improve treatment for these often life-threatening diseases. The Primary Immune Deficiency Treatment Consortium comprises 13 centers throughout the United States and has a $6.25 million funding commitment over five years from the National Institutes of Health.